Twist Bioscience Shares Outstanding 2017-2021 | TWST

Twist Bioscience shares outstanding history from 2017 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Twist Bioscience shares outstanding for the quarter ending June 30, 2021 were 0.049B, a 17.03% increase year-over-year.
  • Twist Bioscience 2020 shares outstanding were 0.039B, a 42.71% increase from 2019.
  • Twist Bioscience 2019 shares outstanding were 0.027B, a 883.24% increase from 2018.
  • Twist Bioscience 2018 shares outstanding were 0.003B, a 15.32% increase from 2017.
Twist Bioscience Annual Shares Outstanding
(Millions of Shares)
2020 39
2019 27
2018 3
2017 2
2016 2
Twist Bioscience Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 49
2021-03-31 49
2020-12-31 46
2020-09-30 39
2020-06-30 42
2020-03-31 37
2019-12-31 33
2019-09-30 27
2019-06-30 30
2019-03-31 28
2018-12-31 19
2018-09-30 3
2018-06-30 3
2018-03-31 3
2017-12-31 3
2017-09-30
2016-09-30
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.526B $0.090B
Twist Bioscience Corporation operates as a biotechnology company. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development and DNA as a digital data storage medium. Twist Bioscience Corporation is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.949B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29